Pfizer Says COVID-19 Vaccine Lawsuit is Based on Bogus Patent | McDermott

McDermott Will & Schulte, a global law firm

COVERAGE

Pfizer Says COVID-19 Vaccine Lawsuit is Based on Bogus Patent

May 31, 2022

Read time: 2 min

Partners, William Gaede, Sarah Chapin Columbia and Ian Brooks are feature in Reuters.

William Gaede

Partner

Silicon Valley, San Francisco

Ian B. Brooks

Partner

Washington, DC

You may also like